Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 13.96
+0.30 (2.20%)
At close: Mar 27, 2026
Jinyu Bio-technology Market Cap
Jinyu Bio-technology has a market cap or net worth of 15.25 billion as of March 27, 2026. Its market cap has increased by 111.06% in one year.
Market Cap
15.25B
Enterprise Value
14.07B
Revenue
1.33B
Ranking
n/a
PE Ratio
145.30
Stock Price
13.96
Market Cap Chart
Since January 18, 1999, Jinyu Bio-technology's market cap has increased from 977.52M to 15.25B, an increase of 1,460.54%. That is a compound annual growth rate of 10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 15.25B | -7.37% |
| Dec 31, 2025 | 16.47B | 114.89% |
| Dec 31, 2024 | 7.66B | -34.56% |
| Dec 29, 2023 | 11.71B | 18.94% |
| Dec 30, 2022 | 9.85B | -46.16% |
| Dec 31, 2021 | 18.29B | -22.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 18.46B |
| Inner Mongolia Furui Medical Science | 15.46B |
| Anhui Anke Biotechnology (Group) | 15.42B |
| Vcanbio Cell & Gene Engineering Corp., | 14.53B |
| Mabwell (Shanghai) Bioscience | 14.51B |
| Staidson (Beijing) BioPharmaceuticals | 13.26B |
| Tibet Cheezheng Tibetan Medicine | 13.02B |
| Chengzhi | 12.65B |